HCC827 GR5 (Q54881790)

From Wikidata

Jump to navigation Jump to search

cell line

HCC827-GR5
HCC-827-GR5
HCC827GR5

Language	Label	Description	Also known as
English	HCC827 GR5	cell line	HCC827-GR5 HCC-827-GR5 HCC827GR5

Statements

1 reference

Cellosaurus release 44

10 January 2023

cancer cell line

1 reference

Cellosaurus release 44

10 January 2023

parent cell line

1 reference

Cellosaurus release 44

10 January 2023

described by source

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

Cellosaurus release 44

10 January 2023

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

1 reference

Cellosaurus release 44

10 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 44

10 January 2023

TAK-701, a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation

1 reference

Cellosaurus release 44

10 January 2023

established from medical condition

adenocarcinoma of the lung

1 reference

Cellosaurus release 44

10 January 2023

derived from organism type

1 reference

Cellosaurus release 44

10 January 2023

Identifiers

1 reference

Cellosaurus release 44

10 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54881790&oldid=1861435148"